These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10101477)

  • 1. [The improvement of echocardiographic assessment of the left ventricle by the use of perflenapent and harmonic imaging].
    Olszewski R; Marciniak W; Nowicki A; Gil M; Etienne J; Karłowicz P; Adamus J
    Pol Merkur Lekarski; 1998 Sep; 5(27):132-4. PubMed ID: 10101477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perflenapent emulsion (EchoGen): a new long-acting phase-shift agent for contrast echocardiography.
    Grayburn P
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I12-8. PubMed ID: 9383597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety assessment of perflenapent emulsion for echocardiographic contrast enhancement in patients with congestive heart failure or chronic obstructive pulmonary disease.
    Kitzman DW; Wesley DJ
    Am Heart J; 2000 Jun; 139(6):1077-80. PubMed ID: 10827390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.
    Grayburn PA; Weiss JL; Hack TC; Klodas E; Raichlen JS; Vannan MA; Klein AL; Kitzman DW; Chrysant SG; Cohen JL; Abrahamson D; Foster E; Perez JE; Aurigemma GP; Panza JA; Picard MH; Byrd BF; Segar DS; Jacobson SA; Sahn DJ; DeMaria AN
    J Am Coll Cardiol; 1998 Jul; 32(1):230-6. PubMed ID: 9669275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies.
    Quay SC; Eisenfeld AJ
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I19-26. PubMed ID: 9383598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying principles of pharmacoeconomic evaluation to perflenapent emulsion, a new echocardiographic contrast agent for use in cardiac function testing.
    Wellman G; Sherrin T
    Clin Ther; 1997; 19(4):837-46. PubMed ID: 9377626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced harmonic color Doppler for left ventricular opacification: improved endocardial border definition compared to tissue harmonic imaging and optimization of methodologyin patients with suboptimal echocardiograms.
    Chen L; Colonna P; Corda M; Cadeddu C; Montisci R; Caiati C; Meloni L; Iliceto S
    Echocardiography; 2001 Nov; 18(8):639-49. PubMed ID: 11801205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
    Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
    J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of harmonic echocardiographic contrast imaging and intravenous bolus of Levovist for evaluation of the left ventricle].
    Kasprzak JD; Drozdz J; Zwierzak M; Borkowski M; Plewka M; Elhendy A; Ten Cate FJ; Roelandt JR; Krzemińska-Pakuła M
    Pol Arch Med Wewn; 2000; 103(1-2):35-40. PubMed ID: 11236256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging.
    Hundley WG; Kizilbash AM; Afridi I; Franco F; Peshock RM; Grayburn PA
    J Am Coll Cardiol; 1998 Nov; 32(5):1426-32. PubMed ID: 9809958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images.
    Kitzman DW; Goldman ME; Gillam LD; Cohen JL; Aurigemma GP; Gottdiener JS
    Am J Cardiol; 2000 Sep; 86(6):669-74. PubMed ID: 10980221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perflenapent emulsion: a US contrast agent for diagnostic radiology--multicenter, double-blind comparison with a placebo. EchoGen Contrast Ultrasound Study Group.
    Robbin ML; Eisenfeld AJ
    Radiology; 1998 Jun; 207(3):717-22. PubMed ID: 9609895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial.
    Crouse LJ; Cheirif J; Hanly DE; Kisslo JA; Labovitz AJ; Raichlen JS; Schutz RW; Shah PM; Smith MD
    J Am Coll Cardiol; 1993 Nov; 22(5):1494-500. PubMed ID: 8227810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety and efficiency of Echogen. Transthoracic echocardiography study].
    Espinola-Zavaleta N; Yánac-Chávez P; Vargas-Barrón J; Romero-Cárdenas A; Roldán-Gómez J
    Gac Med Mex; 2001; 137(3):203-8. PubMed ID: 11432089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New concept in echocardiography: harmonic imaging of tissue without use of contrast agent.
    Caidahl K; Kazzam E; Lidberg J; Neumann Andersen G; Nordanstig J; Rantapää Dahlqvist S; Waldenström A; Wikh R
    Lancet; 1998 Oct; 352(9136):1264-70. PubMed ID: 9788456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. For left ventricular opacification and endocardial border definition: is it really important which contrast agent we use, or is it the imaging modality we choose?
    Dolan MS; El-Shafei A; Puri S; Tamirisa K; St Vrain J; Flanagan J; Havens E; Labovitz AJ
    Eur J Echocardiogr; 2001 Sep; 2(3):154-62. PubMed ID: 11882448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of cardiac output and pulmonary vascular resistance by contrast echocardiography transit time measurement: a prospective pilot study.
    Choi BG; Sanai R; Yang B; Young HA; Mazhari R; Reiner JS; Lewis JF
    Cardiovasc Ultrasound; 2014 Oct; 12():44. PubMed ID: 25361851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of native and contrast-enhanced harmonic echocardiography for visualization of left ventricular endocardial border.
    Kasprzak JD; Paelinck B; Ten Cate FJ; Vletter WB; de Jong N; Poldermans D; Elhendy A; Bouakaz A; Roelandt JR
    Am J Cardiol; 1999 Jan; 83(2):211-7. PubMed ID: 10073823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.